EFFUSIDE-III;2-O-BETA-D-GLUCOPYRANOSYL-1,8-DIMETHYL-2,7-DIHYDROXY-5-HYDROXYMETHYL-9,10-DIHYDRO-PHENANTHRENE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 5zDjAl3yFbS |
|---|---|
| InChI | InChI=1S/C23H28O8/c1-10-13-3-4-14-11(2)17(7-12(8-24)19(14)15(13)5-6-16(10)26)30-23-22(29)21(28)20(27)18(9-25)31-23/h5-7,18,20-29H,3-4,8-9H2,1-2H3/t18-,20-,21+,22-,23-/m1/s1 |
| InChIKey | IXDISBIVWBTTGV-DODNOZFWSA-N |
| Mol Weight | 432.47 g/mol |
| Molecular Formula | C23H28O8 |
| Exact Mass | 432.178418 g/mol |
| Enantiomer InChIKey | IXDISBIVWBTTGV-LCNLMQJVSA-N |
| Copyright | Copyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | Unknown |
EFFUSIDE-IV;12-O-BETA-D-GLUCOPYRANOSYL-1,8-DIMETHYL-2,7-DIHYDROXY-5-HYDROXYMETHYL-9,10-DIHYDRO-PHENANTHRENE
EFFUSIDE-I;12-O-BETA-D-GLUCOPYRANOSYL-1,8-DIMETHYL-2-HYDROXY-5-HYDROXYMETHYL-7-METHOXY-9,10-DIHYDRO-PHENANTHRENE
MARYLAURENCINOSIDE_A;3,4,5-TRIHYDROXY-2-METHOXY-9,10-DIHYDROPHENANTHRENE-4-O-BETA-D-GLUCOPYRANOSIDE
ALANGICADINOSIDE-G;2,3,12-TRIHYDROXYCALAMENENE-3-O-BETA-D-XYLOPYRANOSYL-(1->6)-BETA-D-GLUCOPYRANOSIDE
ALANGICADINOSIDE-F;2,3,12-TRIHYDROXYCALAMENENE-3-O-BETA-D-XYLOPYRANOSYL-(1->6)-BETA-D-GLUCOPYRANOSIDE
Sinensol-D;1-(4-hydroxybenzyl)-2-methoxy-4-hydroxy-8-[2'',2''-dimethylpyrano-[5'',6'':7,8]]-dihydrophenathrene
9'-HYDROXY-CANNABINOL-O-BETA-D-GLUCOPYRANOSIDE
5-O-BETA-D-GLUCOPYRANOSYL-CIRSIMARITIN
MYRCIACITRIN-V;(2S)-6,8-DIMETHYL-5,7,2',5'-TETRAHYDROXY-FLAVANONE-7-O-(6''-O-PARA-HYDROXYBENZOYL)-BETA-D-GLUCOPYRANOSIDE
CANNABINOL-O-BETA-D-GLUCOPYRANOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| Effusides I-V: 9,10-dihydrophenanthrene glucosides from Juncus effusus | Phytochemistry | 1995 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.